Uchino Shigehiko, Fealy Nigel, Baldwin Ian, Morimatsu Hiroshi, Bellomo Rinaldo
Department of Intensive Care and Department of Medicine, Austin and Repatriation Medical Centre Melbourne, 3084, Heidelberg, Victoria, Australia.
Intensive Care Med. 2003 Apr;29(4):575-8. doi: 10.1007/s00134-003-1672-8. Epub 2003 Feb 8.
There is little information on the duration of time that patients spend off therapy (down-time) during continuous veno-venous haemofiltration (CVVH) and the effect of this treatment free time on azotaemic control.
Prospective observational study in the ICU of tertiary hospital.
48 critically ill patients treated with CVVH at 2 l/h of ultrafiltration.
Prospective collection of demographic and biochemical data.
Two hundred and sixty-six filters were observed. Start and end times were collected for each filter. Creatinine and urea were measured daily and percentage of reduction of these two solutes was calculated (%Delta creatinine and urea). The median period when CVVH was not applied to a patient (down-time) was 3 h per day. There was a significant inverse correlation between down-time and %Delta creatinine and urea over each 24-h time cycle. On average at least 16 h per day of CVVH was required to maintain creatinine and urea concentration for each 24-h cycle.
"Continuous" therapy is not truly continuous. Down-time adversely affects azotaemic control. Physicians prescribing CRRT should be aware of the consequences of such down-time on the quality and quantity of renal replacement therapy delivered.
关于患者在持续静脉-静脉血液滤过(CVVH)期间停止治疗的时间(停机时间)以及这段无治疗时间对氮质血症控制的影响,相关信息较少。
在一家三级医院的重症监护病房进行的前瞻性观察研究。
48例接受CVVH治疗且超滤速度为2 l/h的重症患者。
前瞻性收集人口统计学和生化数据。
共观察了266个滤器。记录每个滤器的开始和结束时间。每天测量肌酐和尿素,并计算这两种溶质的降低百分比(肌酐和尿素的%Δ)。CVVH未应用于患者的中位时间(停机时间)为每天3小时。在每个24小时周期内,停机时间与肌酐和尿素的%Δ之间存在显著的负相关。平均每天至少需要16小时的CVVH来维持每个24小时周期内的肌酐和尿素浓度。
“持续”治疗并非真正连续。停机时间对氮质血症控制有不利影响。开具连续性肾脏替代治疗(CRRT)处方的医生应意识到这种停机时间对所提供的肾脏替代治疗的质量和数量的影响。